Meningitis and Prevnar
By THE ASSOCIATED PRESS (copyright)
16 September 2004
Filed at 1:20 p.m. ET
ATLANTA (AP) -- Replenished supplies of a childhood meningitis vaccine has prompted health officials Thursday to lift a previous recommendation that doctors postpone some of the shots.
All four shots of the vaccine Prevnar may now be given to children between 2 months and 15 months. Because of shortages earlier this year, the Centers for Disease Control and Prevention recommended in March that doctors give just two doses.
The CDC's Advisory Committee on Immunization Practices, the American Academy of Family Physicians and the American Academy of Pediatrics lifted the limits placed on the vaccine because manufacturer Wyeth Pharmaceuticals now is able to make more of the vaccine.
The prior shortages were attributed to production problems.
Prevnar is used to protect children against invasive pneumococcal disease, which can lead to meningitis or bloodstream infections.